No merit seen in including Paxlovid in Covid treatment: ICMR https://ift.tt/l1gQMqk

Antiviral drug Molnupiravir, earlier failed to convince the ICMR for its inclusion in India's national Covid-19 treatment protocol due to "safety concerns", even as it received an emergency use authorisation (EUA) from the country's drug regulator.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/EmN7pao
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.